Contraception, ISSN 0010-7824, 06/2018, Volume 97, Issue 6, pp. 524 - 532
To measure the 24-month impact on continuation, unintended pregnancy and satisfaction of trying long-acting reversible contraception (LARC) in a population...
Adherence | Long-acting reversible contraception | Randomized | Unintended pregnancy | Acceptability, contraceptive continuation | WOMEN | PATIENT PREFERENCE TRIAL | OBSTETRICS & GYNECOLOGY | Long-Acting Reversible Contraception - methods | Humans | Contraceptive Agents, Female - administration & dosage | Long-Acting Reversible Contraception - psychology | Patient Preference | Pregnancy | Young Adult | Contraceptives, Oral | Injections | Patient Satisfaction - statistics & numerical data | Pregnancy, Unplanned | Adolescent | Long-Acting Reversible Contraception - statistics & numerical data | Adult | Female | Surveys and Questionnaires | Women | Contraceptives | Rankings | Contraception | Pregnant women | Health aspects | oral contraceptives | LARC | subdermal contraceptive implant | contraceptive continuation | adherence | unintended pregnancy | IUD | DMPA | acceptability
Adherence | Long-acting reversible contraception | Randomized | Unintended pregnancy | Acceptability, contraceptive continuation | WOMEN | PATIENT PREFERENCE TRIAL | OBSTETRICS & GYNECOLOGY | Long-Acting Reversible Contraception - methods | Humans | Contraceptive Agents, Female - administration & dosage | Long-Acting Reversible Contraception - psychology | Patient Preference | Pregnancy | Young Adult | Contraceptives, Oral | Injections | Patient Satisfaction - statistics & numerical data | Pregnancy, Unplanned | Adolescent | Long-Acting Reversible Contraception - statistics & numerical data | Adult | Female | Surveys and Questionnaires | Women | Contraceptives | Rankings | Contraception | Pregnant women | Health aspects | oral contraceptives | LARC | subdermal contraceptive implant | contraceptive continuation | adherence | unintended pregnancy | IUD | DMPA | acceptability
Journal Article
2.
Full Text
Hormonal contraception and HIV acquisition: Reanalysis using marginal structural modeling
AIDS, ISSN 0269-9370, 07/2010, Volume 24, Issue 11, pp. 1778 - 1781
Hormonal contraceptives are used widely worldwide; their effect on HIV acquisition remains unresolved. We reanalyzed data from the Hormonal Contraception and...
SURVIVAL | INFECTIOUS DISEASES | VIROLOGY | RISK | ANTIRETROVIRAL THERAPY | INFECTION | COHORT | IMMUNOLOGY | INFERENCE | AGE | HIV-1 | Young Adult | Contraceptives, Oral, Hormonal - adverse effects | Epidemiologic Methods | HIV Infections - epidemiology | Humans | Adolescent | Medroxyprogesterone Acetate - adverse effects | Adult | Female | HIV Infections - transmission | Contraceptives, Oral, Combined - adverse effects
SURVIVAL | INFECTIOUS DISEASES | VIROLOGY | RISK | ANTIRETROVIRAL THERAPY | INFECTION | COHORT | IMMUNOLOGY | INFERENCE | AGE | HIV-1 | Young Adult | Contraceptives, Oral, Hormonal - adverse effects | Epidemiologic Methods | HIV Infections - epidemiology | Humans | Adolescent | Medroxyprogesterone Acetate - adverse effects | Adult | Female | HIV Infections - transmission | Contraceptives, Oral, Combined - adverse effects
Journal Article
JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 06/2014, Volume 66, Issue 2, pp. 109 - 117
OBJECTIVE:Hormonal contraception (HC), younger age, and pregnancy have been associated with increased HIV risk in some studies. We sought to elucidate the...
HIV-1 | hormonal contraception | immunity | cervical inflammation | pregnancy | INFECTIOUS DISEASES | ACQUISITION | IMMUNOLOGY | LEUKOCYTE PROTEASE INHIBITOR | GENITAL-TRACT | BIOMARKERS | WOMEN | TRICHOMONAS-VAGINALIS | TRANSMISSION | HIGH-RISK | IMMUNODEFICIENCY-VIRUS TYPE-1 | INFECTION | Contraceptive Agents, Female - adverse effects | Inflammation - chemically induced | Prospective Studies | Humans | Contraceptive Agents, Female - administration & dosage | Uganda - epidemiology | Case-Control Studies | Chemokine CCL5 - blood | Young Adult | Chemokine CCL20 - blood | Secretory Leukocyte Peptidase Inhibitor - blood | Medroxyprogesterone Acetate - adverse effects | Adult | Female | HIV Seropositivity - immunology | Cytokines - blood | Cervix Uteri - drug effects | Zimbabwe - epidemiology | Immunity, Innate - drug effects | Risk Factors | Pregnancy | Adolescent | Cervix Uteri - immunology | HIV Seropositivity - epidemiology | Medroxyprogesterone Acetate - administration & dosage
HIV-1 | hormonal contraception | immunity | cervical inflammation | pregnancy | INFECTIOUS DISEASES | ACQUISITION | IMMUNOLOGY | LEUKOCYTE PROTEASE INHIBITOR | GENITAL-TRACT | BIOMARKERS | WOMEN | TRICHOMONAS-VAGINALIS | TRANSMISSION | HIGH-RISK | IMMUNODEFICIENCY-VIRUS TYPE-1 | INFECTION | Contraceptive Agents, Female - adverse effects | Inflammation - chemically induced | Prospective Studies | Humans | Contraceptive Agents, Female - administration & dosage | Uganda - epidemiology | Case-Control Studies | Chemokine CCL5 - blood | Young Adult | Chemokine CCL20 - blood | Secretory Leukocyte Peptidase Inhibitor - blood | Medroxyprogesterone Acetate - adverse effects | Adult | Female | HIV Seropositivity - immunology | Cytokines - blood | Cervix Uteri - drug effects | Zimbabwe - epidemiology | Immunity, Innate - drug effects | Risk Factors | Pregnancy | Adolescent | Cervix Uteri - immunology | HIV Seropositivity - epidemiology | Medroxyprogesterone Acetate - administration & dosage
Journal Article
Contraception, ISSN 0010-7824, 2009, Volume 79, Issue 5, pp. 356 - 362
Abstract Background The copper intrauterine device (IUD) can cause side effects in some women; increased uterine bleeding and pain may cause early removal....
Obstetrics and Gynecology | Copper IUD | Longitudinal analysis | Side effects | Intrauterine device | MENSTRUAL BLOOD-LOSS | LEVONORGESTREL | VAGINAL BLEEDING PATTERNS | CONTRACEPTION | TCU 380AG | OBSTETRICS & GYNECOLOGY | WOMEN | USERS | INTRAUTERINE-DEVICES | Young Adult | Device Removal | Menstruation | Follow-Up Studies | Intrauterine Devices, Copper - adverse effects | Time Factors | Humans | Middle Aged | Adolescent | Adult | Female | longitudinal analysis | copper IUD | side effects | intrauterine device
Obstetrics and Gynecology | Copper IUD | Longitudinal analysis | Side effects | Intrauterine device | MENSTRUAL BLOOD-LOSS | LEVONORGESTREL | VAGINAL BLEEDING PATTERNS | CONTRACEPTION | TCU 380AG | OBSTETRICS & GYNECOLOGY | WOMEN | USERS | INTRAUTERINE-DEVICES | Young Adult | Device Removal | Menstruation | Follow-Up Studies | Intrauterine Devices, Copper - adverse effects | Time Factors | Humans | Middle Aged | Adolescent | Adult | Female | longitudinal analysis | copper IUD | side effects | intrauterine device
Journal Article
American Journal of Obstetrics and Gynecology, ISSN 0002-9378, 2016, Volume 216, Issue 2, pp. 101 - 109
Background Measures of contraceptive effectiveness combine technology and user-related factors. Observational studies show higher effectiveness of long-acting...
Obstetrics and Gynecology | oral contraceptives | long-acting reversible contraception | LARC | adherence | contraceptive continuation | discontinuation | subdermal contraceptive implant | unintended pregnancy | depot medroxyprogesterone acetate | intrauterine device | acceptability | UNITED-STATES | IMPLEMENTATION | OBSTETRICS & GYNECOLOGY | RATES | NEEDS | IUDS | CONTINUATION | Contraceptives, Oral, Hormonal - therapeutic use | Contraceptive Agents, Female - therapeutic use | Humans | Kaplan-Meier Estimate | Medroxyprogesterone Acetate - therapeutic use | Desogestrel - therapeutic use | Drug Implants | Patient Preference | Intrauterine Devices, Medicated | Pregnancy | Young Adult | Intrauterine Devices | Patient Acceptance of Health Care | Pregnancy, Unplanned | Intrauterine Devices, Copper | Adolescent | Adult | Female | Delayed-Action Preparations | Contraception - methods | Contraceptives | Pregnant women | Analysis | Methods | Oral contraceptives | Implants, Artificial | Prosthesis
Obstetrics and Gynecology | oral contraceptives | long-acting reversible contraception | LARC | adherence | contraceptive continuation | discontinuation | subdermal contraceptive implant | unintended pregnancy | depot medroxyprogesterone acetate | intrauterine device | acceptability | UNITED-STATES | IMPLEMENTATION | OBSTETRICS & GYNECOLOGY | RATES | NEEDS | IUDS | CONTINUATION | Contraceptives, Oral, Hormonal - therapeutic use | Contraceptive Agents, Female - therapeutic use | Humans | Kaplan-Meier Estimate | Medroxyprogesterone Acetate - therapeutic use | Desogestrel - therapeutic use | Drug Implants | Patient Preference | Intrauterine Devices, Medicated | Pregnancy | Young Adult | Intrauterine Devices | Patient Acceptance of Health Care | Pregnancy, Unplanned | Intrauterine Devices, Copper | Adolescent | Adult | Female | Delayed-Action Preparations | Contraception - methods | Contraceptives | Pregnant women | Analysis | Methods | Oral contraceptives | Implants, Artificial | Prosthesis
Journal Article
The Pediatric Infectious Disease Journal, ISSN 0891-3668, 01/2017, Volume 36, Issue 8, pp. 768 - 773
BACKGROUND:Adolescents living with HIV (ALHIV) experience less favorable antiretroviral therapy (ART) outcomes than other age groups. First–line treatment...
Medication Adherence - statistics & numerical data | Cross-Sectional Studies | HIV Infections - epidemiology | Humans | Adolescent | Proportional Hazards Models | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | HIV Infections - psychology | Male | Zambia - epidemiology
Medication Adherence - statistics & numerical data | Cross-Sectional Studies | HIV Infections - epidemiology | Humans | Adolescent | Proportional Hazards Models | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | HIV Infections - psychology | Male | Zambia - epidemiology
Journal Article
PLoS Medicine, ISSN 1549-1277, 01/2015, Volume 12, Issue 1, pp. 1 - 26
Background Observational studies of a putative association between hormonal contraception (HC) and HIV acquisition have produced conflicting results. We...
VAGINAL GEL | MICROBICIDES DEVELOPMENT PROGRAM | WOMEN | MEDICINE, GENERAL & INTERNAL | TRANSMISSION | VIRUS-INFECTION | FEMALE SEX WORKERS | PATIENT DATA | DOUBLE-BLIND | PREVENTION | REPRODUCTIVE AGE | Contraceptive Agents, Female - adverse effects | HIV Infections - prevention & control | HIV Infections - epidemiology | Humans | Middle Aged | Risk Factors | Contraceptive Agents, Female - administration & dosage | Norethindrone - administration & dosage | Norethindrone - analogs & derivatives | Incidence | Norethindrone - adverse effects | Adolescent | Medroxyprogesterone Acetate - adverse effects | Adult | Female | HIV Infections - transmission | Medroxyprogesterone Acetate - administration & dosage | Africa South of the Sahara - epidemiology | Studies | Birth control | Family planning | Human immunodeficiency virus | HIV | Womens health
VAGINAL GEL | MICROBICIDES DEVELOPMENT PROGRAM | WOMEN | MEDICINE, GENERAL & INTERNAL | TRANSMISSION | VIRUS-INFECTION | FEMALE SEX WORKERS | PATIENT DATA | DOUBLE-BLIND | PREVENTION | REPRODUCTIVE AGE | Contraceptive Agents, Female - adverse effects | HIV Infections - prevention & control | HIV Infections - epidemiology | Humans | Middle Aged | Risk Factors | Contraceptive Agents, Female - administration & dosage | Norethindrone - administration & dosage | Norethindrone - analogs & derivatives | Incidence | Norethindrone - adverse effects | Adolescent | Medroxyprogesterone Acetate - adverse effects | Adult | Female | HIV Infections - transmission | Medroxyprogesterone Acetate - administration & dosage | Africa South of the Sahara - epidemiology | Studies | Birth control | Family planning | Human immunodeficiency virus | HIV | Womens health
Journal Article
AIDS Research and Human Retroviruses, ISSN 0889-2229, 10/2018, Volume 34, Issue 10, pp. 889 - 899
Hormonal contraception (HC), particularly injectable depot-medroxyprogesterone acetate (DMPA), has been associated with increased HIV acquisition and higher...
Transmission
Transmission
Journal Article
9.
Full Text
Pain from copper intrauterine device insertion: Randomized trial of prophylactic ibuprofen
American Journal of Obstetrics and Gynecology, ISSN 0002-9378, 2006, Volume 195, Issue 5, pp. 1272 - 1277
This study was undertaken to determine whether 400 mg of prophylactic ibuprofen can alleviate pain from insertion of an intrauterine device (IUD) and to...
Prevention | Insertion | Pain | Ibuprofen | Intrauterine device | CONTRACEPTIVE EFFICACY | pain | ibuprofen | IUD | RISK | insertion | intrauterine device | prevention | DEVELOPING-COUNTRIES | OBSTETRICS & GYNECOLOGY | Ibuprofen - therapeutic use | Double-Blind Method | Intrauterine Devices, Copper - adverse effects | Lactation | Humans | Analgesics, Non-Narcotic - therapeutic use | Pregnancy | Pain - drug therapy | Pain - physiopathology | Treatment Failure | Aging | Pain - etiology | Adult | Female | Pain Measurement | Parity | Intrauterine contraceptives | Usage | Research | Risk factors
Prevention | Insertion | Pain | Ibuprofen | Intrauterine device | CONTRACEPTIVE EFFICACY | pain | ibuprofen | IUD | RISK | insertion | intrauterine device | prevention | DEVELOPING-COUNTRIES | OBSTETRICS & GYNECOLOGY | Ibuprofen - therapeutic use | Double-Blind Method | Intrauterine Devices, Copper - adverse effects | Lactation | Humans | Analgesics, Non-Narcotic - therapeutic use | Pregnancy | Pain - drug therapy | Pain - physiopathology | Treatment Failure | Aging | Pain - etiology | Adult | Female | Pain Measurement | Parity | Intrauterine contraceptives | Usage | Research | Risk factors
Journal Article
AIDS (London, England), ISSN 0269-9370, 2012, Volume 26, Issue 4, pp. 497 - 504
Objectives: To evaluate the effect of hormonal contraception including combined oral contraceptives (COCs), and the injectable progestins...
hormonal contraception | HIV acquisition | oral contraceptives | Africa | depo-provera | heterosexual transmission | women | SURVIVAL | INFECTIOUS DISEASES | MARGINAL STRUCTURAL MODELS | ANTIRETROVIRAL THERAPY | IMMUNOLOGY | INFERENCE | VIROLOGY | INFECTION | COHORT | Humans | Middle Aged | South Africa - epidemiology | Contraceptives, Oral, Hormonal - administration & dosage | Proportional Hazards Models | Sexual Behavior - statistics & numerical data | HIV Seropositivity - transmission | Norethindrone - administration & dosage | Norethindrone - analogs & derivatives | Incidence | Pregnancy | Young Adult | Anti-Infective Agents - administration & dosage | Adolescent | HIV Seropositivity - epidemiology | Adult | Female | Medroxyprogesterone Acetate - administration & dosage | Vaginal Creams, Foams, and Jellies - administration & dosage | Odds Ratio
hormonal contraception | HIV acquisition | oral contraceptives | Africa | depo-provera | heterosexual transmission | women | SURVIVAL | INFECTIOUS DISEASES | MARGINAL STRUCTURAL MODELS | ANTIRETROVIRAL THERAPY | IMMUNOLOGY | INFERENCE | VIROLOGY | INFECTION | COHORT | Humans | Middle Aged | South Africa - epidemiology | Contraceptives, Oral, Hormonal - administration & dosage | Proportional Hazards Models | Sexual Behavior - statistics & numerical data | HIV Seropositivity - transmission | Norethindrone - administration & dosage | Norethindrone - analogs & derivatives | Incidence | Pregnancy | Young Adult | Anti-Infective Agents - administration & dosage | Adolescent | HIV Seropositivity - epidemiology | Adult | Female | Medroxyprogesterone Acetate - administration & dosage | Vaginal Creams, Foams, and Jellies - administration & dosage | Odds Ratio
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 2/2008, Volume 197, Issue 4, pp. 548 - 554
Background. Trichomoniasis vaginalis is the most common nonviral sexually transmitted infection (STI) world-wide, with a particularly high prevalence in...
Polymerase chain reaction | HIV/AIDS | HIV infections | HIV | Microscopy | Predisposing factors | Coitus | Human herpesvirus 2 | AIDS | Infections | HIV 1 | INFECTIOUS DISEASES | SEXUALLY-TRANSMITTED-DISEASES | SPECIMENS | RISK | MICROBIOLOGY | IMMUNOLOGY | TYPE-1 | HIV-1 TRANSMISSION | Trichomonas vaginalis - pathogenicity | HIV-1 - pathogenicity | Zimbabwe - epidemiology | Prevalence | HIV Seropositivity - parasitology | HIV Infections - epidemiology | Humans | Risk Factors | Uganda - epidemiology | Trichomonas Vaginitis - complications | Case-Control Studies | Trichomonas Vaginitis - epidemiology | Animals | Trichomonas Vaginitis - ethnology | Adolescent | HIV Infections - complications | Ambulatory Care Facilities | Adult | Female | HIV Infections - ethnology | Longitudinal Studies | Women | Demographic aspects | Trichomoniasis | Development and progression | Reports | Research | HIV infection | Health aspects | Risk factors
Polymerase chain reaction | HIV/AIDS | HIV infections | HIV | Microscopy | Predisposing factors | Coitus | Human herpesvirus 2 | AIDS | Infections | HIV 1 | INFECTIOUS DISEASES | SEXUALLY-TRANSMITTED-DISEASES | SPECIMENS | RISK | MICROBIOLOGY | IMMUNOLOGY | TYPE-1 | HIV-1 TRANSMISSION | Trichomonas vaginalis - pathogenicity | HIV-1 - pathogenicity | Zimbabwe - epidemiology | Prevalence | HIV Seropositivity - parasitology | HIV Infections - epidemiology | Humans | Risk Factors | Uganda - epidemiology | Trichomonas Vaginitis - complications | Case-Control Studies | Trichomonas Vaginitis - epidemiology | Animals | Trichomonas Vaginitis - ethnology | Adolescent | HIV Infections - complications | Ambulatory Care Facilities | Adult | Female | HIV Infections - ethnology | Longitudinal Studies | Women | Demographic aspects | Trichomoniasis | Development and progression | Reports | Research | HIV infection | Health aspects | Risk factors
Journal Article
Acta clinica Belgica, ISSN 1784-3286, 07/2015, p. 2295333715Y0000000052
The authors reported a 56-year-old man with progressive pain over left bottom of oral cavity involving tongue for 3 days. He had a puncture history of tongue...
Journal Article
Epidemiology (Cambridge, Mass.), ISSN 1044-3983, 11/2011, Volume 22, Issue 6, pp. 877 - 878
Journal Article
AIDS Research and Human Retroviruses, ISSN 0889-2229, 05/2016, Volume 32, Issue 5, pp. 443 - 451
Background: Cervicovaginal HIV shedding is associated with increased female-to-male and mother-to-child transmission. Genital inflammation may increase...
Immunology | Chemokine CCL20 - metabolism | Cervix Uteri - virology | Virus Shedding - immunology | Cytokines - analysis | HIV Infections - virology | Humans | Biomarkers - analysis | Inflammation - immunology | Vascular Endothelial Growth Factor A - metabolism | Seroconversion | Young Adult | HIV Infections - immunology | HIV-1 - immunology | Intercellular Adhesion Molecule-1 - metabolism | Interleukin-1beta - metabolism | Interleukin 1 Receptor Antagonist Protein - metabolism | Adolescent | Vagina - virology | Adult | Female | Chemokine CCL5 - metabolism | Interleukin-8 - metabolism | Interleukin-6 - metabolism | Secretory Leukocyte Peptidase Inhibitor - metabolism
Immunology | Chemokine CCL20 - metabolism | Cervix Uteri - virology | Virus Shedding - immunology | Cytokines - analysis | HIV Infections - virology | Humans | Biomarkers - analysis | Inflammation - immunology | Vascular Endothelial Growth Factor A - metabolism | Seroconversion | Young Adult | HIV Infections - immunology | HIV-1 - immunology | Intercellular Adhesion Molecule-1 - metabolism | Interleukin-1beta - metabolism | Interleukin 1 Receptor Antagonist Protein - metabolism | Adolescent | Vagina - virology | Adult | Female | Chemokine CCL5 - metabolism | Interleukin-8 - metabolism | Interleukin-6 - metabolism | Secretory Leukocyte Peptidase Inhibitor - metabolism
Journal Article
AIDS Research and Human Retroviruses, ISSN 0889-2229, 02/2017
Journal Article
PLoS medicine, 06/2018, Volume 15, Issue 6, p. e1002608
Journal Article
AIDS Research and Human Retroviruses, ISSN 0889-2229, 11/2016, Volume 32, Issue 10-11, pp. 167 - 1071
The acute phase of HIV infection carries substantial risk of transmission; identification of acute-phase infections may offer opportunities to reduce that...
SMARTube | acute infection | seroconversion | HIV infection | ANTIBODIES | INFECTIOUS DISEASES | ISRAEL | DONORS | IMMUNOLOGY | ETHIOPIAN IMMIGRANTS | TRANSMISSION | WINDOW PERIOD | VIROLOGY | TYPE-1 | HIV Antibodies - analysis | Predictive Value of Tests | Prospective Studies | Cross-Sectional Studies | Follow-Up Studies | Humans | Middle Aged | Cell Culture Techniques - methods | Incidence | Young Adult | Vietnam | Diagnostic Tests, Routine - methods | HIV Infections - diagnosis | Adult | Female | South Africa | Developing Countries
SMARTube | acute infection | seroconversion | HIV infection | ANTIBODIES | INFECTIOUS DISEASES | ISRAEL | DONORS | IMMUNOLOGY | ETHIOPIAN IMMIGRANTS | TRANSMISSION | WINDOW PERIOD | VIROLOGY | TYPE-1 | HIV Antibodies - analysis | Predictive Value of Tests | Prospective Studies | Cross-Sectional Studies | Follow-Up Studies | Humans | Middle Aged | Cell Culture Techniques - methods | Incidence | Young Adult | Vietnam | Diagnostic Tests, Routine - methods | HIV Infections - diagnosis | Adult | Female | South Africa | Developing Countries
Journal Article
mBio, ISSN 2161-2129, 2015, Volume 6, Issue 5, p. e00221
Particular types of hormonal contraceptives (HCs) and genital tract infections have been independently associated with risk of HIV-1 acquisition. We examined...
TRICHOMONAS-VAGINALIS | SEXUALLY-TRANSMITTED INFECTIONS | NORETHISTERONE ACETATE | HIV ACQUISITION | CERVICAL INFLAMMATION | MEDROXYPROGESTERONE ACETATE | MICROBIOLOGY | FEMALE REPRODUCTIVE-TRACT | BLOOD PROTEIN CONCENTRATIONS | GENITAL-TRACT | BACTERIAL VAGINOSIS | Contraceptives, Oral, Hormonal - adverse effects | Disease Susceptibility | Immunomodulation | Humans | Contraceptives, Oral, Hormonal - administration & dosage | Immunologic Factors - administration & dosage | Young Adult | Reproductive Tract Infections - immunology | Adolescent | Adult | HIV Infections - transmission | Uganda | Zimbabwe | Immunologic Factors - adverse effects | Medroxyprogesterone - administration & dosage | Medroxyprogesterone - adverse effects
TRICHOMONAS-VAGINALIS | SEXUALLY-TRANSMITTED INFECTIONS | NORETHISTERONE ACETATE | HIV ACQUISITION | CERVICAL INFLAMMATION | MEDROXYPROGESTERONE ACETATE | MICROBIOLOGY | FEMALE REPRODUCTIVE-TRACT | BLOOD PROTEIN CONCENTRATIONS | GENITAL-TRACT | BACTERIAL VAGINOSIS | Contraceptives, Oral, Hormonal - adverse effects | Disease Susceptibility | Immunomodulation | Humans | Contraceptives, Oral, Hormonal - administration & dosage | Immunologic Factors - administration & dosage | Young Adult | Reproductive Tract Infections - immunology | Adolescent | Adult | HIV Infections - transmission | Uganda | Zimbabwe | Immunologic Factors - adverse effects | Medroxyprogesterone - administration & dosage | Medroxyprogesterone - adverse effects
Journal Article